In Canada, a Wegrovy prescription costs just over $400 a month, said Michael Law, who holds the Canada Research Chair in Access to Medicines at the University of British Columbia.

Credits: envato elements; Author: maksymiv;

The treatment, which targets adults with cardiovascular disease and BMI of 27 or higher, is the first Health Canada approved drug for both chronic weight management and reducing the risk of myocardial infarction.